Related Experiment Video
Updated: Jun 12, 2026

Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
miR-33 links SREBP-2 induction to repression of sterol transporters
Tyler J Marquart1, Ryan M Allen, Daniel S Ory
1Edward A Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St Louis, MO 63104, USA.
Abstract:
The sterol regulatory element binding protein 2 (SREBP-2) and the liver X receptor (LXR) control antagonistic transcriptional programs that stimulate cellular cholesterol uptake and synthesis, and cholesterol efflux, respectively. The clinical importance of SREBP-2 is revealed in patients with hypercholesterolemia treated with statins, which reduce low-density lipoprotein (LDL) cholesterol levels by increasing hepatic expression of SREBP-2 and its target, the LDL receptor. Here we show that miR-33 is encoded within SREBP-2 and that both mRNAs are coexpressed. We also identify sequences in the 3' UTR of ABCA1 and ABCG1, sterol transporter genes both previously shown to be regulated by LXR, as targets for miR-33-mediated silencing. Our data show that LXR-dependent cholesterol efflux to both ApoAI and serum is ameliorated by miR-33 overexpression and, conversely, stimulated by miR-33 silencing. Finally, we show that ABCA1 mRNA and protein and plasma HDL levels decline after hepatic overexpression of miR-33, whereas they increase after hepatic miR-33 silencing. These results suggest novel ways to manage hypercholesterolemic patients.
Insights
MicroRNA-33 (miR-33), encoded within SREBP-2, regulates cholesterol homeostasis. Overexpression of miR-33 impairs cholesterol efflux, while silencing enhances it, offering potential therapeutic strategies for hypercholesterolemia.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Sterol regulatory element binding protein 2 (SREBP-2) and liver X receptor (LXR) govern opposing cholesterol pathways.
- SREBP-2 upregulates cellular cholesterol uptake and synthesis, crucial in hypercholesterolemia management.
- LXR promotes cholesterol efflux, a key mechanism for maintaining cholesterol balance.
Purpose of the Study:
- To investigate the role of microRNA-33 (miR-33) in cholesterol metabolism.
- To determine the relationship between SREBP-2, LXR, and miR-33.
- To explore the therapeutic potential of modulating miR-33 for hypercholesterolemia.
Main Methods:
- Investigated coexpression of SREBP-2 and miR-33.
- Identified ABCA1 and ABCG1 3' UTRs as targets for miR-33-mediated silencing.
- Assessed the impact of miR-33 modulation on LXR-dependent cholesterol efflux and HDL levels in hepatic models.
Main Results:
- miR-33 is encoded within SREBP-2, leading to their coexpression.
- miR-33 directly targets and silences ABCA1 and ABCG1, key cholesterol transporters.
- Overexpression of miR-33 inhibits cholesterol efflux and reduces HDL levels, while silencing has the opposite effect.
Conclusions:
- miR-33 acts as a negative regulator of cholesterol efflux by targeting ABCA1 and ABCG1.
- Modulating miR-33 levels presents a novel therapeutic avenue for managing hypercholesterolemia.
- The interplay between SREBP-2, miR-33, and LXR offers new insights into cholesterol homeostasis regulation.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of the Unfolded Protein Response
Lipid Catabolism
Cholesterol: Significance and Regulation
Considering cholesterol and...
Receptor-mediated Endocytosis
